Your browser doesn't support javascript.
loading
Comparison of the Pathological Response and Adverse Effects of Oxaliplatin and Capecitabine versus Paclitaxel and Carboplatin in the Neoadjuvant Chemoradiotherapy Treatment Approach for Esophageal and Gastroesophageal Junction Cancer: A Randomized Control Trial Study.
Cheraghi, Aida; Barahman, Maedeh; Hariri, Ramyar; Nikoofar, Alireza; Fadavi, Pedram.
  • Cheraghi A; Department of Radiotherapy, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Barahman M; Department of Radiotherapy, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Hariri R; Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nikoofar A; Department of Radiotherapy, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Fadavi P; Department of Radiotherapy, Shohaday-e-Haftom-e-Tir Hospital, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran ; 35: 140, 2021.
Article en En | MEDLINE | ID: mdl-35321371
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Año: 2021 Tipo del documento: Article